Structure Therapeutics logo

Structure Therapeutics share price today

(GPCR)

Structure Therapeutics share price is $27.9 & ₹2,370.83 as on 21 Dec 2024, 2.30 'hrs' IST

$27.9

-2.07

(-6.91%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Structure Therapeutics share price in Dollar and Rupees. Guide to invest in Structure Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Structure Therapeutics. Get details on the Indian mutual funds that are investing in Structure Therapeutics. Get Analyst recommendations and forecasts along with all the Structure Therapeutics's financials.

Structure Therapeutics share price movements

  • Today's Low: $27.49
    Today's High: $30.66

    Day's Volatility :10.32%

  • 52 Weeks Low: $26.23
    52 Weeks High: $62.74

    52 Weeks Volatility :58.19%

Structure Therapeutics Returns

PeriodStructure Therapeutics, Inc.Index (Russel 2000)
3 Months
-34.12%
0.0%
6 Months
-36.13%
0.0%
1 Year
-21.45%
0.0%
3 Years
7.31%
-19.7%

Structure Therapeutics Key Statistics

in dollars & INR

Previous Close
$29.97
Open
$30.79
Today's High
$30.655
Today's Low
$27.49
Market Capitalization
$1.7B
Today's Volume
$1.7M
52 Week High
$62.74
52 Week Low
$26.23
Revenue TTM
$0.0
EBITDA
$-121.8M
Earnings Per Share (EPS)
$-2.16
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-17.69%

How to invest in Structure Therapeutics from India?

It is very easy for Indian residents to invest directly in Structure Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Structure Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Structure Therapeutics or GPCR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Structure Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Structure Therapeutics shares which would translate to 0.030 fractional shares of Structure Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Structure Therapeutics, in just a few clicks!

Returns in Structure Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Structure Therapeutics investment value today

Current value as on today

₹1,23,649

Returns

₹23,649

(+23.65%)

Returns from Structure Therapeutics Stock

₹21,453 (false-21.45%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Structure Therapeutics

12.59%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Investment in Structure Therapeutics from India has grown in the last 30 days as on Dec 22, 2024. 12.59% more purchase transactions for Structure Therapeutics in the last 30 days versus the previous period.

177%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Structure Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 22, 2024. 177% more investors are searching Structure Therapeutics in the last 30 days versus the previous period.

Analyst Recommendation on Structure Therapeutics

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Structure Therapeutics(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
12
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Structure Therapeutics

What analysts predicted

Upside of 207.35%

Current:

$27.90

Target:

$85.75

Insights on Structure Therapeutics

  • Price Movement

    In the last 7 days, GPCR stock has moved down by -10.7%
  • GPCR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 51.0%

Structure Therapeutics Technicals Summary

Sell

Neutral

Buy

Structure Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Structure Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Structure Therapeutics, Inc.
-16.49%
-36.13%
-21.45%
7.31%
7.31%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.38%
12.23%
86.41%
Biontech Se
4.48%
30.56%
7.97%
-55.71%
237.85%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.37%
26.29%
108.55%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-2.55%
77.79%
80.12%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Structure Therapeutics, Inc.
NA
NA
NA
-0.76
-0.18
-0.13
NA
9.76
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Structure Therapeutics, Inc.
Buy
$1.7B
7.31%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
86.41%
17.51
33.61%
Biontech Se
Buy
$26.7B
237.85%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
108.55%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.12%
32.84
-4.51%

Structure Therapeutics Dividend announcements

  • Structure Therapeutics Earnings

    Structure Therapeutics’s price-to-earnings ratio stands at None

    Read More

About Structure Therapeutics

Organization
Structure Therapeutics
Employees
136
CEO
Dr. Raymond C. Stevens Ph.D.
Industry
Healthcare

Management People of Structure Therapeutics

NameTitle
Dr. Raymond C. Stevens Ph.D.
CEO & Director
Mr. Jun S. Yoon
Co- Founder, CFO & Secretary
Dr. Yingli Ma Ph.D.
Chief Technology Officer
Dr. Xichen Lin Ph.D.
Chief Scientific Officer
Mr. Tony Peng
Senior Vice President of Legal
Mr. Bob Gatmaitan
Senior Vice President of People
Dr. Hui Lei Ph.D.
Senior Vice President of Chemistry
Dr. Fang Zhang Ph.D.
Executive VP & Head of Biology
Ms. Lani Ibarra
Senior Vice President of Clinical Development Operations
Dr. Xinglong Jiang Ph.D.
Senior Vice President of Preclinical Development

Important FAQs about investing in Structure Therapeutics from India :

What is Structure Therapeutics share price today?

Structure Therapeutics share price today stands at $27.90, Open: $30.79 ; Previous Close: $29.97 ; High: $30.66 ; Low: $27.49 ; 52 Week High: $62.74 ; 52 Week Low: $26.23. The stock opens at $30.79, after a previous close of $29.97. The stock reached a daily high of $30.66 and a low of $27.49, with a 52-week high of $62.74 and a 52-week low of $26.23.

Can Indians buy Structure Therapeutics shares?

Yes, Indians can invest in the Structure Therapeutics (GPCR) from India.

With INDmoney, you can buy Structure Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Structure Therapeutics at zero transaction cost.

How can I buy Structure Therapeutics shares from India?

It is very easy to buy Structure Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Structure Therapeutics be purchased?

Yes, you can buy fractional shares of Structure Therapeutics with INDmoney app.

What are the documents required to start investing in Structure Therapeutics stocks?

To start investing in Structure Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Structure Therapeutics

Today’s highest price of Structure Therapeutics (GPCR) is $30.66.

Today’s lowest price of Structure Therapeutics (GPCR) is $27.49.

What is today's market capitalisation of Structure Therapeutics

Today's market capitalisation of Structure Therapeutics GPCR is 1.7B

What is the 52 Week High and Low Range of Structure Therapeutics

  • 52 Week High

    $62.74

  • 52 Week Low

    $26.23

What are the historical returns of Structure Therapeutics?

  • 1 Month Returns

    -16.49%

  • 3 Months Returns

    -36.13%

  • 1 Year Returns

    -21.45%

  • 5 Years Returns

    7.31%

Who is the Chief Executive Officer (CEO) of Structure Therapeutics

Dr. Raymond C. Stevens Ph.D. is the current Chief Executive Officer (CEO) of Structure Therapeutics.